<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="italic;} Am J Trop Med HygAm. J. Trop. Med. HygtpmdtropmedThe" exact="American" post="Journal of Tropical Medicine and Hygiene0002-96371476-1645The American Society of"/>
 <result pre="Trop. Med. HygtpmdtropmedThe American Journal of Tropical Medicine and Hygiene0002-96371476-1645The" exact="American" post="Society of Tropical Medicine and Hygiene pmcid: 7410434tpmd200642 doi:"/>
 <result pre="[11], [12], [13], [14], *Address correspondence to Jean B. Nachega," exact="Infectious" post="Diseases and Microbiology, Graduate School of Public Health and"/>
 <result pre="[12], [13], [14], *Address correspondence to Jean B. Nachega, Infectious" exact="Diseases" post="and Microbiology, Graduate School of Public Health and Center"/>
 <result pre="have been disclosed. Financial support: J. B. N. is an" exact="infectious disease" post="internist and epidemiologist supported by U.S. National Institutes of"/>
 <result pre="been disclosed. Financial support: J. B. N. is an infectious" exact="disease" post="internist and epidemiologist supported by U.S. National Institutes of"/>
 <result pre="U.S. National Institutes of Health (NIH)/National Institutes of Allergy and" exact="Infectious" post="Diseases grant number 5U01AI069521 (Stellenbosch University Clinical Trial Unit"/>
 <result pre="National Institutes of Health (NIH)/National Institutes of Allergy and Infectious" exact="Diseases" post="grant number 5U01AI069521 (Stellenbosch University Clinical Trial Unit of"/>
 <result pre="coprincipal investigator of the Pan-African Network on Emerging and Re-Emerging" exact="Infections" post="(PANDORA-ID-NET; https://www.pandora-id.net/) funded by the EU Horizon 2020 Framework"/>
 <result pre="addresses: Jean B. Nachega, Department of Medicine and Centre for" exact="Infectious" post="Diseases, Faculty of Medicine and Health Sciences, Stellenbosch University,"/>
 <result pre="School of Public Health, Baltimore, MD, and Department of Epidemiology," exact="Infectious" post="Diseases and Microbiology, Center for Global Health, University of"/>
 <result pre="of Public Health, Baltimore, MD, and Department of Epidemiology, Infectious" exact="Diseases" post="and Microbiology, Center for Global Health, University of Pittsburgh,"/>
 <result pre="of Public Health, New York, NY, E-mail: sm3966@cumc.columbia.edu. Joel Breman," exact="American" post="Society of Tropical Medicine and Hygiene, Oakbrook Terrace, IL,"/>
 <result pre="Republic of the Congo, E-mail: amstev04@yahoo.fr. Alimuddin Zumla, Division of" exact="Infection" post="and Immunity, Department of Infection, Centre for Clinical Microbiology,"/>
 <result pre="has reported 4,258 COVID-19 cases with 90 deaths. With other" exact="African" post="countries, the DRC faces the challenge of striking a"/>
 <result pre="the population and negative impacts on health services for other" exact="infectious" post="and noninfectious diseases. The DRC recently controlled its tenth"/>
 <result pre="noninfectious diseases. The DRC recently controlled its tenth Ebola virus" exact="disease" post="(EVD) outbreak, but COVID-19 and a new EVD outbreak"/>
 <result pre="spread of COVID-19 compounds the burden on health services in" exact="African" post="countries that have experienced recurrent outbreaks of deadly zoonotic"/>
 <result pre="burden on health services in African countries that have experienced" exact="recurrent" post="outbreaks of deadly zoonotic diseases in recent years. As"/>
 <result pre="135,412 COVID-19 cases, with 3,236 deaths from 45 countries.1 Most" exact="African" post="countries are facing difficult decisions as they attempt to"/>
 <result pre="limit the spread of SARS-CoV-2, control local outbreaks of other" exact="infectious diseases," post="and lessen economic hardships and food insecurity for large"/>
 <result pre="of the Congo (DRC) recently experienced its tenth Ebola virus" exact="disease" post="(EVD) outbreak, the second largest globally after the 2014â€&quot;2016"/>
 <result pre="(EVD) outbreak, the second largest globally after the 2014â€&quot;2016 West" exact="African" post="epidemic, which was recently brought under control. The lessons"/>
 <result pre="response to COVID-19 and associated challenges, priorities, and innovations for" exact="disease" post="control. EPIDEMIOLOGICAL SNAPSHOT Early COVID-19 cases in Africa were"/>
 <result pre="March 10, 2020. Two days after returning from France, an" exact="adult" post="male with cough and fever tested positive in the"/>
 <result pre="early index cases in Kinshasa also occurred among young affluent" exact="adult" post="travelers from Europe.3 The DRC declared a state of"/>
 <result pre="of 2.1%) as of June 11, 2020.1 To date, the" exact="disease" post="has spread to 11 provinces and 54 (10% of"/>
 <result pre="in the DRC (Figures 1 and 2). As in other" exact="African" post="countries, the travel bans and lockdowns have had negative"/>
 <result pre="including standard public health measures (surveillance, contact-tracing, active case finding," exact="infection" post="prevention and control, risk communication, community engagement, and safe"/>
 <result pre="to face the challenge of having back-to-back EVD outbreaks with" exact="limited" post="funding for existing needs. On June 1, 2020, the"/>
 <result pre="According to the WHO, as of June 9, 2020, a" exact="total" post="of 12 EVD cases (nine confirmed and three probable)"/>
 <result pre="with COVID-19 may be asymptomatic, contact-tracing includes the collection of" exact="respiratory" post="samples on days 7 and 12 from all high-risk"/>
 <result pre="experience using contact-tracers and community health workers (CHCWs) at the" exact="peripheral" post="level: health areas, neighborhoods, and villages. Fourth, the EVD"/>
 <result pre="proportion of 92% (Table 1). Among reported confirmed cases, a" exact="total" post="of 1,176 (44.2%) were symptomatic (Figure 2).7,8 Various organizations"/>
 <result pre="Among reported confirmed cases, a total of 1,176 (44.2%) were" exact="symptomatic" post="(Figure 2).7,8 Various organizations involved in the COVID-19 fight"/>
 <result pre="the suspected case meets the case definition for COVID-19, a" exact="respiratory" post="sample is taken, and the person is quarantined at"/>
 <result pre="Republic of the Congo (March 10, 2020â€&quot;May 27, 2020) Province" exact="Total" post="health zones Affected health zones Total confirmed cases Total"/>
 <result pre="2020â€&quot;May 27, 2020) Province Total health zones Affected health zones" exact="Total" post="confirmed cases Total contacts Contacts traced N % N"/>
 <result pre="Province Total health zones Affected health zones Total confirmed cases" exact="Total" post="contacts Contacts traced N % N % Kinshasa 35"/>
 <result pre="Higher Katanga 27 5 19 21 337 337 100 Kongo" exact="Central" post="31 5 16 189 760 742 98 South Kivu"/>
 <result pre="the current gold standard test for the diagnosis of SARS-CoV-2" exact="infection" post="is detection of viral RNA in a sample from"/>
 <result pre="test for the diagnosis of SARS-CoV-2 infection is detection of" exact="viral" post="RNA in a sample from the respiratory tract by"/>
 <result pre="is detection of viral RNA in a sample from the" exact="respiratory" post="tract by RT-PCR.9â€&quot;11 Laboratories with skilled staff and the"/>
 <result pre="Africa, is an attractive option, but drawbacks include cost and" exact="limited" post="supplies of SARS-CoV-2 cartridges. PoC viral antigen detection is"/>
 <result pre="drawbacks include cost and limited supplies of SARS-CoV-2 cartridges. PoC" exact="viral" post="antigen detection is not yet sufficiently sensitive.14 Serological testing"/>
 <result pre="measures, and handwashing Some community members do not believe that" exact="disease" post="exists Scale-up community COVID-19 sensitization and barrier measure messages"/>
 <result pre="infrastructure, human resources, medical management and training platform of Ebola" exact="Viral" post="Disease for COVID-19 Increase resources in affected provinces and"/>
 <result pre="human resources, medical management and training platform of Ebola Viral" exact="Disease" post="for COVID-19 Increase resources in affected provinces and adequate"/>
 <result pre="(e.g., protective equipment, medical equipment, medicines, and means of transportation)" exact="Limited" post="technical capacity of COVID-19 case management among healthcare providers"/>
 <result pre="infrastructure, human resources, medical management, and training platform of Ebola" exact="viral" post="disease for COVID-19 Limited logistical resources to carry out"/>
 <result pre="human resources, medical management, and training platform of Ebola viral" exact="disease" post="for COVID-19 Limited logistical resources to carry out response"/>
 <result pre="management, and training platform of Ebola viral disease for COVID-19" exact="Limited" post="logistical resources to carry out response activities in the"/>
 <result pre="to carry out response activities in the provinceâ€™s remote areas" exact="Increased" post="numbers of multidisciplinary healthcare workers and trained CHWs Ensure"/>
 <result pre="in the DRC.17 Weak health systems in the DRC, with" exact="limited" post="intensive care beds, oxygen supply, ventilators, and trained staff,"/>
 <result pre="workers, a series of in-service COVID-19 training modules covering triage," exact="infection" post="prevention and control, testing, maintenance of essential services, and"/>
 <result pre="by the case management commission with support from technical partners." exact="Bilateral" post="and multilateral partnerships are scaling-up donations including medical and"/>
 <result pre="to clinical staff to ensure optimal care and prevention of" exact="infection" post="of healthcare workers.18 Remaining challenges and priority solutions are"/>
 <result pre="Nachega also serves on the scientific program committee of the" exact="American" post="Society of Tropical Medicine and Hygiene (ASTMH) and is"/>
 <result pre="pandemic of COVID-19. References REFERENCES 1.collab: World Health Organization, 2020Coronavirus" exact="Disease" post="(COVID-2019) Situation Reports. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed June 2,"/>
 <result pre="national level based on lessons learned from the Ebola virus" exact="disease" post="outbreak in the Democratic Republic of the Congo. Am"/>
 <result pre="Med Hyg103: 12â€&quot;17.32431285 7.MulanguSet al.2019A rendomized trial of Ebola virus" exact="disease" post="therapeutics. N Engl J Med381: 2293â€&quot;2303.31774950 8.RohanHMcKayG, 2020The Ebola"/>
 <result pre="COVID-19. Available at: https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19. Accessed April 21, 2020. 15.OkbaNMAet al.2020Severe" exact="acute" post="respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease"/>
 <result pre="Available at: https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19. Accessed April 21, 2020. 15.OkbaNMAet al.2020Severe acute" exact="respiratory" post="syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019"/>
 <result pre="at: https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19. Accessed April 21, 2020. 15.OkbaNMAet al.2020Severe acute respiratory" exact="syndrome" post="coronavirus 2-specific antibody responses in coronavirus disease 2019 patients."/>
 <result pre="al.2020Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus" exact="disease" post="2019 patients. Emerg Infect Dis26, 10.3201/eid2607.200841. 16.collab: World Health"/>
</results>
